Many of these advances are the result of decades of work and clinical trials. Since the mid-1990s, the American Cancer ...

The ACS estimates that 626,140 people in the U.S. will die from cancer in 2026, amounting to about 1,720 deaths per day. Lung ...

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Thai Minister of Public Health Pattana Promphat led a delegation to China’s Gansu province to strengthen cooperation in ...

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

The therapies available for cancer treatment have improved dramatically in recent years. Advances made during the past several decades have led to increasingly longer survival times and reductions in ...

The QUILT-2.005 trial is a randomized registrational study designed to evaluate the effectiveness of ANKTIVA® combined with BCG in BCG-naïve patients. As of January 2026, enrollment has surpassed 85%, ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

The Richard and Melanie Gonzmart Adolescent & Young Adult Cancer Program addresses the special needs of TGH cancer patients ages 15 and up. TAMPA, Fla., Jan. 15, 2026 /PRNewswire/ -- The Tampa General ...